Healthcare training platform MedAll has raised £2.5 million in a seed funding round as it moves to expand its reach to thousands of organisations and millions of healthcare professionals.
The Belfast-based company, which is backed by Seedcamp, Ascension, and Techstart, offers a platform that helps healthcare organisations to manage, deliver and share virtual and hybrid training courses and conferences. Its platform launched in February 2021.
The round was backed by a number of investors including angel investor Sarah Friar, who was the recipient of Digital DNA’s highly renowned Global Recognition of the Year Award 2021. The Northern Ireland-born boss of the Nextdoor social network said MedAll has “an ambitious team building a product that already has global reach”
Other investors include London-based Connect Ventures and Nina Capital, a Barcelona-based health technology fund.
MedAll will use the funding to develop its products and make the virtual training software accessible to thousands more organisations to help them train additional healthcare workers in the next 18 months.
“The World Health Organisation explains that we need to train an additional 18 million healthcare professionals by 2030. But The Lancet describes ‘severe institutional shortages’ in our training capacity. If we don’t solve this problem, patients will suffer. It was this urgent need that motivated me to launch MedAll,” said Dr Phil McElnay, Co-founder and chief executive of MedAll. “We’re honoured to have the backing of such stellar partners to help us to scale up the world’s healthcare training capacity.”
MedAll has already facilitated healthcare training sessions for more than 900 organisations around the world.